Glenmark Pharmaceuticals Ltd.
ShareGLENMARK Share price chart
*Stock prices shown are delayed by 5 minutes
Key Indicators
Data as per latest reports and statements
| Today's low/high | ₹1,861.70 / ₹1,908.00 |
| 52-week low/high | ₹1,275.50 / ₹2,284.80 |
| Circuit range | ₹1,679.49 / ₹2,052.71 |
| Market cap | ₹52,661 Cr |
| PE ratio (TTM) | 50.29 |
| Sector PE | 38.93 |
| ROE | 6.78% |
| ROCE | 9.76% |
| Basic EPS (TTM) | ₹37.10 |
| Diluted EPS | ₹37.11 |
| Book Value per share | ₹868.42 |
| Face Value per share | ₹1 |
| PB ratio | 2.15 |
| Debt to equity | 0.03 |
| Dividend Yield | 0.13% |
| EBITDA Margin (TTM) | 18.50% |
Returns calculator
- Total investment₹10,000
- Profit+ ₹2,346
- Dividends+ ₹35
- Total corpus₹12,381
- Absolute returns23.81%
Financials
FY 25- Metric
- Value
- YoY growth
- Operating Revenue
₹9,226 Cr
- EBITDA
₹2,601 Cr
- Profit Before Tax
₹2,154 Cr
- Profit After Tax
₹1,610 Cr
About Glenmark Pharmaceuticals Ltd.
Business Verticals & Subsidiaries
- Glenmark Impex LLC
- Glenmark Farmaceutica Ltda
- Glenmark Pharmaceuticals Inc. USA
- Glenmark Pharmaceuticals (Nigeria) Ltd.
- Glenmark Pharmaceuticals (Australia) Pty.Ltd.
Glenmark Pharmaceuticals Ltd. Stock Market Performance
- Nifty Midcap 150
- Nifty 500
- Nifty 200
- Nifty LargeMidcap 250
- Nifty Midcap 100
The Latest Details of GLENMARK Earnings
The Latest Updates on GLENMARK Share Price
Glenmark Pharmaceuticals Ltd.'s Board of Directors
| Name | Position |
|---|---|
| Mr. Glenn Saldanha | Chairman & Managing Director |
| Mrs. Cherylann Pinto | Executive Director |
| Mr. Anurag Mantri | Executive Director & Global CFO |
GLENMARK Shares FAQs
Glenmark Pharmaceuticals Ltd.'s total assets as of 31 Mar 2025 stood at Rs.16,050 Cr.
Glenmark Pharmaceuticals Ltd.'s share price as of 21 Nov 2025 is Rs.1,866.10. Over the past 1 month, Glenmark Pharmaceuticals Ltd.'s share price has decreased by 0.54%.
The market cap of Glenmark Pharmaceuticals Ltd. stood at Rs.52,661 Cr as of 21 Nov 2025.
SALDANHA FAMILY TRUST:Holds a stake of 45.45%
BLANCHE ELIZABETH SALDANHA:Holds a stake of 0.39%
GLENN MARIO SALDANHA:Holds a stake of 0.35%
The PE ratio of Glenmark Pharmaceuticals Ltd. is 50.29, and the PB ratio is 2.15.
Glenmark Pharmaceuticals Ltd. was established in 1977.
To analyze Glenmark Pharmaceuticals Ltd. stock, start by researching the company's financial health, including its revenue, profit margins, debt levels, and cash flow. Look into industry trends, competition, and any recent news or developments that might impact Glenmark Pharmaceuticals Ltd..
The 52-week low for Glenmark Pharmaceuticals Ltd.'s share price was Rs.1,275.50 and the 52-week high was Rs.2,284.80.
21 Nov 2025 Stock Performance for Glenmark Pharmaceuticals Ltd.
On Friday, 21 Nov 2025, Glenmark Pharmaceuticals Ltd.'s stocks opened at Rs.1,878.40 and closed at Rs.1,866.10. The day's trading saw the stock reach a high of Rs.1,908 and a low of Rs.1,861.70.
Glenmark Pharmaceuticals Ltd. is listed on NSE. It is also listed on BSE.
